David Weiner named executive vice president at The Wistar Institute

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

DAVID WEINER was named executive vice president of The Wistar Institute, director of the Vaccine Center, and the W. W. Smith Endowed Chair in Cancer Research. Weiner will also contribute tumor immunology-focused research as a professor in Wistar’s Translational Tumor Immunology program. Previously, Weiner was a professor of pathology and laboratory medicine at the University...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Twenty years ago, the discovery of epidermal growth factor receptor mutations as drivers of tumorigenesis and viable targets for therapeutic intervention marked the beginning of a new era in lung cancer diagnosis and treatment. Since then, the field has made remarkable progress towards developing more effective targeted treatments and immunotherapies that have significantly improved patient outcomes and survival.

Login